Seed develops clinically-studied probiotics to impact human and planetary health.
Seed has raised $925K in total funding. The most recent round was Undisclosed. The last funding was announced in July 2022.
Seed's investors include Alumni Ventures, BoxGroup, Greycroft, Valia Ventures, M13.
Seed is headquartered in Venice, United States.
Seed develops clinically-studied probiotics to impact human and planetary health.
Seed is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seed — Funding & Investors." VCBacked, July 19, 2022, https://www.vcbacked.co/company/seed. Accessed September 2, 2026.
VCBacked. (2022). Seed — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/seed
{{cite web |title=Seed — Funding & Investors |url=https://www.vcbacked.co/company/seed |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated